The fight against cancer is entering a new era, one defined by personalised treatment and precision medicine. In recent years, there has been a notable increase in the number of large-scale biobanks being established, providing researchers with access to a vast array of biological specimens alongside associated clinical data, such as medical records, family history, lifestyle information, and genetic data. However, traditional biobanking methods usually involve cryogenic storage using ultra-low temperature freezers or liquid nitrogen, a process which often compromises cell viability. This limitation restricts the use of specimens to processes such as the extraction of proteins, DNA, or RNA, and prevents the cultivation of live cells, which significantly hinders their potential to advance precision medicine.